Haleon plc (HLN)
USD 9.71
(-2.02%)
USD 9.71
(-2.02%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 11.3 Billion GBP | 4.09% |
| 2022 | 10.85 Billion GBP | 13.76% |
| 2021 | 9.54 Billion GBP | -3.51% |
| 2020 | 9.89 Billion GBP | 16.65% |
| 2019 | 8.48 Billion GBP | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.91 Billion GBP | 5.53% |
| 2024 Q2 | 2.77 Billion GBP | -4.93% |
| 2023 Q4 | 2.76 Billion GBP | -1.14% |
| 2023 FY | 11.3 Billion GBP | 4.09% |
| 2023 Q3 | 2.79 Billion GBP | 1.67% |
| 2023 Q2 | 2.75 Billion GBP | -7.84% |
| 2023 Q1 | 2.98 Billion GBP | -21.28% |
| 2022 Q3 | 2.89 Billion GBP | 12.92% |
| 2022 Q1 | 2.62 Billion GBP | 79.32% |
| 2022 Q4 | 3.79 Billion GBP | 31.15% |
| 2022 FY | 10.85 Billion GBP | 13.76% |
| 2022 Q2 | 2.56 Billion GBP | -2.51% |
| 2021 Q2 | 2.26 Billion GBP | -1.6% |
| 2021 Q3 | 2.49 Billion GBP | 9.74% |
| 2021 Q4 | 1.46 Billion GBP | -41.16% |
| 2021 Q1 | 2.3 Billion GBP | 0.0% |
| 2021 FY | 9.54 Billion GBP | -3.51% |
| 2020 FY | 9.89 Billion GBP | 16.65% |
| 2019 FY | 8.48 Billion GBP | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.39 Billion USD | -372.174% |
| Bausch Health Companies Inc. | 8.75 Billion USD | -29.062% |
| Catalent, Inc. | 4.38 Billion USD | -157.978% |
| Emergent BioSolutions Inc. | 1.04 Billion USD | -977.099% |
| Elanco Animal Health Incorporated | 4.41 Billion USD | -155.875% |
| Perrigo Company plc | 4.65 Billion USD | -142.761% |
| Teva Pharmaceutical Industries Limited | 15.84 Billion USD | 28.676% |
| Zoetis Inc. | 8.54 Billion USD | -32.28% |